Nearly one-third of breast cancer survivors face relapse. Adopting healthy lifestyle habits—like proper diet, exercise, and ...

The biotechnology company said its Bria-IMT plus check point inhibitors showed a 17.3-month survival rate for patients with hormone receptor-positive breast cancer, exceeding the 14.4 months of ...

Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ ...

Hormone receptor (HR)-positive HER2-negative advanced breast cancer is incurable and the aim of treatment is to delay it getting worse and extend how long people live. If the cancer has alterations in ...

Talk show icon Trisha Goddard was diagnosed with stage four breast cancer in 2023 after previously beating the disease.

The TV icon, 67, best known for her self-titled talk show Trisha, confirmed the return of her secondary breast cancer, which ...

In trials, in 708 women, when combined with hormone therapy, the drug doubled the time the cancer took to grow, from 3.6 ...

Thousands of women with advanced breast cancer in England and Wales are to be offered a "gamechanging" twice-a-day pill on ...

A "huge breakthrough" in breast cancer treatment has arrived with the NHS approval of a twice-daily pill for the most common form of advanced disease. At such a critical moment in US history, we need ...

Professor Nicholas Turner, from the Institute of Cancer Research, tells Sky News that capivasertib is a "great success story ...

Women with advanced breast cancer could soon have access to a new targeted treatment on the NHS, following a decision by the National Institute for Health and Care Excellence (NICE). The tablet ...

Results from a clinical trial showed that capivasertib plus the hormone therapy fulvestrant increased the time before the ...